CEREZYME
CEREZYME
Approved
DIN Number
02241751
Drug Class
Human
Market Date
Jun 14, 2000
Company
HC
sanofi-aventis canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02241751
AIG Number0131511002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
A16AB02 IMIGLUCERASE
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification44:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
IMIGLUCERASEActive
Strength: 400 UNIT / VIAL
Monograph: IMIGLUCERASE